References

1. Russell, W.C. Update on adenovirus and its vectors. J. Gen. Virol. 2000, 81 (Pt 11), 2573-2604.

2. Smith, T.A.; Idamakanti, N.; Marshall-Neff, J.; Rollence, M.L.; Wright, P.; Kaloss, M.; King, L.; Mech, C.; Dinges, L.; Iverson, W.O.; Sherer, A.D.; Markovits, J.E.; Lyons, R.M.; Kaleko, M.; Stevenson, S.C. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. Hum. Gene Ther. 2003, 14 (17), 1595-1604.

3. Ogawara, K.; Rots, M.G.; Kok, R.J.; Moorlag, H.E.; Loenen, A.; Meijer, D.K.F.; Haisma, H.J.; Molema, G. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum. Gene Ther. 2004, 15 (5), 433-443.

4. Haviv, Y.S.; Curiel, D.T. Conditional gene targeting for cancer gene therapy. Adv. Drug Deliv. Rev. 2001, 53 (2), 135-154.

5. Heise, C.; Sampson-Johannes, A.; Williams, A.; McCor-mick, F.; Von Hoff, D.D.; Kirn, D.H. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytoly-sis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 1997, 3 (6), 639-645.

6. De Weese, T.L.; van der Poel, H.; Li, S.; Mikhak, B.; Drew, R.; Goemann, M.; Hamper, U.; DeJong, R.; Detorie, N.; Rodriguez, R.; Haulk, T.; DeMarzo, A.M.; Piantadosi, S.; Yu, D.C.; Chen, Y.; Henderson, D.R.; Carducci, M.A.; Nelson, W.G.; Simons, J.W. A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res. 2001, 61 (20), 7464-7472.

7. Rots, M.G.; Curiel, D.T.; Gerritsen, W.R.; Haisma, H.J. Targeted cancer gene therapy: The flexibility of adenoviral gene therapy vectors. J. Control. Release 2003, 87 (1-3), 159-165.

8. Haviv, Y.S.; Curiel, D.T. Engineering regulatory elements for conditionally-replicative adeno-viruses. Curr. Gene Ther. 2003, 3 (4), 357-385.

9. Hernandez-Alcoceba, R.; Pihalja, M.; Qian, D.; Clarke, M.F. New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication. Hum. Gene Ther. 2002, 13 (14), 1737-1750.

10. Reynolds, P.N.; Nicklin, S.A.; Kaliberova, L.; Boatman, B.G.; Grizzle, W.E.; Balyasnikova, I.V.; Baker, A.H.; Danilov, S.M.; Curiel, D.T. Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat. Biotechnol. 2001, 19 (9), 838-842.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment